Full-Time

Lead Program Integrator

Magnetic Resonance

Updated on 9/12/2026

GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

No salary listed

No H1B Sponsorship

Waukesha, WI, USA

In Person

Bachelor's, Master's

Category
Project & Program Management (1)
Required Skills
Agile
UI/UX Design
Risk Management

Get referred to GE Healthcare

See people who can refer or advise you

Requirements
  • A bachelor's degree in Engineering, Science, or a related discipline, or equivalent experience defined as a high school diploma or GED with a minimum of four additional years of progressive experience as an engineer or scientist within the relevant field.
  • A minimum of six years of experience in engineering, program, or project leadership roles within a manufacturing, development, or research environment, including demonstrated leadership of global and/or virtual teams and delivery against quality, performance, schedule, and budget expectations.
  • The ability to build strong, sustained cross-functional relationships, supported by communication, influence, and stakeholder management skills.
  • Experience leading software-related projects or partnering closely with software teams, with the ability to understand software development activities, risks, dependencies, and delivery expectations.
  • Understanding of and hands-on experience with the New Product Introduction lifecycle, including management of complex cross-functional dependencies.
  • Commitment to quality and compliance, including awareness of and adherence to the GE HealthCare Quality Manual, Quality Management System, Quality Management Policy, Quality Goals, and applicable laws and regulations relevant to the role.
  • Completion of all required Quality and Compliance training within established timelines.
  • The ability to proactively identify, communicate, and escalate quality or compliance concerns and take timely corrective action as required.
Responsibilities
  • Lead resource, material, and integrated program planning to ensure disciplined, on-time execution of program commitments.
  • Own delivery of program milestones, budgets, metrics, deliverables, and associated action items using project management tools and governance routines.
  • Lead design transfer activities to ensure a seamless transition from development into manufacturing and downstream functions.
  • Drive program reliability outcomes in close partnership with Systems and Reliability Engineering teams.
  • Execute day-to-day program activities within the overall program plan, using SAFe planning practices to support prioritization, dependency management, and cross-functional alignment in coordination with the Program Manager.
  • Partner with system, subsystem/platform, and service leadership teams to deliver products on schedule, within cost targets, and with required features.
  • Identify, plan, and track program integration steps, defining ownership, scope, timing, dependencies, and escalation paths.
  • Identify, assess, and manage program risks and issues, developing contingency plans and tracking mitigation actions to closure.
  • Establish and maintain communication mechanisms to enable alignment, transparency, and execution rigor across global business units, functions, program teams, third-party partners, and business leadership.
  • Establish cost target baselines, track progress across product and service-related cost elements, and communicate NPI product cost status to the program core team and business leadership.
  • Align program cost management activities with MR product and service productivity initiatives, leveraging common tools and synchronized efforts.
  • Ensure all regulatory deliverables are met by working closely with Regulatory Affairs and cross-functional stakeholders throughout the program lifecycle.
  • Lead planning, scheduling, and execution of global cross-functional teams, including UX Design, Usability, Software Engineering, firmware, and hardware teams, while operating within the SAFe framework.
  • Lead change through creative solutions to product, process, and system design issues.
  • Support M&A integration activities by coordinating third-party software integration, aligning acquired capabilities with MR product workflows, and partnering with software subject matter experts to assess software quality, maturity, readiness, and integration risk.
Desired Qualifications
  • A master's degree in Engineering, specifically Mechanical, Electrical, or a related discipline.
  • Working knowledge of Agile development frameworks and their application in complex product development environments.
  • Prior experience assessing and integrating M&A products and capabilities.
  • Experience with full software development lifecycle development of complex software applications.
  • Experience with NPI-related ISO and regulatory compliance processes, including development and maintenance of Design History Files.
  • The ability to think creatively and develop effective solutions when navigating competing technical requirements, business priorities, and program risks.
  • A strong track record of proactively identifying product and program risks, driving cross-functional alignment, and leading risk mitigation actions to closure.
  • Familiarity with GE HealthCare engineering tools and processes, such as MyWorkshop and PPM.
  • The ability to work independently and manage multiple priorities to achieve timely, high-quality outcomes.
  • The ability to develop innovative concepts and solutions for complex, integrated products and systems.
  • Project or program leadership experience within manufacturing, development, or research environments in the healthcare industry.
  • Broad exposure to hardware, software, and systems design, with technical depth in one or more engineering disciplines, such as Electrical, Mechanical, or Software.
  • Experience leading or contributing to global, multi-site development programs.
  • Graduation from GE HealthCare's Edison Engineering Development Program.

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Photonova Spectra won CE Mark on August 31, 2026, opening Europe sales.
  • Q2 2026 orders rose 11.1%, with 1.15x book-to-bill and record backlog.
  • Vivid cardiovascular ultrasound and ABUS breast screening launches broaden 2026 revenue opportunities.

What critics are saying

  • Patient Care Solutions revenue fell 13.5% in Q2 2026; management is reviewing a sale.
  • Jay Saccaro left in August 2026; William Grogan starts September 14, 2026.
  • If PCS recovery slips into 2027, GE HealthCare becomes a slower-growth imaging vendor.

What makes GE Healthcare unique

  • Photonova Spectra’s Deep Silicon CT differentiates GE HealthCare with photon-counting imaging.
  • GE HealthCare spans imaging, pharma diagnostics, ultrasound, and monitoring across hospital workflows.
  • The July 2026 backlog of $23.9 billion reflects sticky installed-base demand and services.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

Yahoo Finance
Sep 1st, 2026
GE HealthCare secures CE mark for Photonova Spectra photon-counting CT system

GE HealthCare has received CE mark approval for its Photonova Spectra photon-counting computed tomography system, enabling commercial sales in markets recognising CE marking. The clearance follows US Food and Drug Administration approval and Japanese regulatory clearance in March 2026. The system uses GE HealthCare's Deep Silicon detector technology to deliver ultra-high definition spectral and spatial imaging. It processes data volumes up to 50 times greater than conventional CT systems, utilising Nvidia's accelerated computing platform. Clinical collaborations are underway at UZ Brussel in Belgium and Rigshospitalet in Denmark to evaluate the system across cardiology, neurology, oncology and musculoskeletal imaging. The CE mark follows more than $5 billion in innovation investment by GE HealthCare.

Yahoo Finance
Aug 31st, 2026
Vertex Pharmaceuticals shows promise while GE HealthCare and Wells Fargo face challenges

Vertex Pharmaceuticals has emerged as a standout S&P 500 stock, according to StockStory's analysis. The company, which focuses on developing transformative medicines for serious diseases including cystic fibrosis and sickle cell disease, boasts a market capitalisation of $137.3 billion. Meanwhile, StockStory recommends avoiding two large-cap stocks. GE HealthCare, spun off from General Electric in 2023, faces concerns over stagnant organic revenue growth and declining operating margins. The medical equipment provider has a market cap of $32.4 billion. Wells Fargo also made the avoid list. The diversified financial services company, with a $262.2 billion market cap, has seen its net interest margin shrink by 33.6 basis points over two years, suggesting increased competition or declining loan profitability.

Associated Press
Aug 28th, 2026
GE HealthCare launches three new Vivid cardiovascular ultrasound systems for diverse care settings

GE HealthCare has introduced three new cardiovascular ultrasound systems to its Vivid portfolio: Vivid Explorer 1, Vivid Advanced 1, and Vivid Focus 1. The systems were unveiled at the European Society of Cardiology Congress 2026 in Munich, Germany. Each system targets different clinical settings whilst sharing a common technology foundation with the ultra-premium Vivid Pioneer. Vivid Explorer is designed for high-volume echo labs, Vivid Advanced for mid-size hospitals and cardiology practices, and Vivid Focus for everyday cardiac imaging. All three systems use cSound imaging technology and include AI-enabled automation tools to streamline echo workflows. The systems have received CE Mark approval but are awaiting US FDA 510(k) clearance and are not yet available for sale in the United States.

Yahoo Finance
Aug 3rd, 2026
GE HealthCare launches Invenia ABUS Prime and StreamVue for breast cancer screening

GE HealthCare has launched Invenia ABUS Prime and ABUS StreamVue, expanding its breast imaging portfolio with solutions for supplemental screening in women with dense breasts. The Invenia ABUS Prime system has been installed at BeSound in Los Angeles, marking one of the first US installations. ABUS StreamVue is a browser-based reading solution enabling remote exam review across imaging networks. The system received FDA 510(k) clearance and CE Marking. Studies show 40% of women have dense breasts, carrying four to six times higher breast cancer risk. Research indicates mammography may miss one-third of cancers in dense breasts. Invenia ABUS Prime features AI-enabled tools including Scan Quality Assessment and can increase scan speed by up to 40%. The AI Assistant has demonstrated a 33% reduction in reading time.

Yahoo Finance
Jul 29th, 2026
GE HealthCare Q2: Orders up 11%, backlog hits record $23.9B amid Patient Care struggles

GE HealthCare Technologies reported second-quarter results with orders rising 11% year-over-year and backlog reaching a record $23.9 billion. Revenue grew 3.5% organically to $5.3 billion, driven by Advanced Imaging Solutions and Pharmaceutical Diagnostics, which posted organic growth of 5% and 14.6% respectively. Patient Care Solutions remained weak, with revenue falling 13.5% due to component shortages and fulfilment problems. Management is reviewing strategic options for the segment, including a potential sale. The company maintained its full-year outlook of 3–4% organic sales growth, adjusted earnings per share of $4.80–$5.00, and approximately $1.6 billion in free cash flow. CFO Jay Saccaro is departing, with George Newcomb serving as interim CFO.